|
|
Volumn 174, Issue 3, 2005, Pages 1011-
|
|
Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ETAMSYLATE;
EVIPROSTAT;
NAFTOPIDIL;
NAPHTHALENE DERIVATIVE;
PIPERAZINE DERIVATIVE;
PLANT EXTRACT;
ARTICLE;
BLADDER OBSTRUCTION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECT;
EPIDEMIOLOGY;
HUMAN;
MALE;
MUSCLE HYPERTONIA;
PHYTOTHERAPY;
PROSTATE HYPERTROPHY;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
TREATMENT OUTCOME;
URODYNAMICS;
ADRENERGIC ALPHA-ANTAGONISTS;
BIAS (EPIDEMIOLOGY);
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
ETHAMSYLATE;
HUMANS;
MALE;
MUSCLE HYPERTONIA;
NAPHTHALENES;
PHYTOTHERAPY;
PIPERAZINES;
PLANT EXTRACTS;
PROSTATIC HYPERPLASIA;
SINGLE-BLIND METHOD;
TREATMENT OUTCOME;
URINARY BLADDER NECK OBSTRUCTION;
URODYNAMICS;
|
|
EID: 25144519703
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1097/01.ju.0000171855.70549.4e Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
